You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ARTANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Artane, and when can generic versions of Artane launch?

Artane is a drug marketed by Lederle and is included in two NDAs.

The generic ingredient in ARTANE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ARTANE?
  • What are the global sales for ARTANE?
  • What is Average Wholesale Price for ARTANE?
Summary for ARTANE
Drug patent expirations by year for ARTANE
Recent Clinical Trials for ARTANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Mental Health CenterEarly Phase 1
Bachmann Strauss Dystonia & Parkinson Foundation, Inc.
University of Florida

See all ARTANE clinical trials

US Patents and Regulatory Information for ARTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle ARTANE trihexyphenidyl hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 006773-010 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ARTANE trihexyphenidyl hydrochloride TABLET;ORAL 006773-005 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ARTANE trihexyphenidyl hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 012947-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ARTANE trihexyphenidyl hydrochloride ELIXIR;ORAL 006773-009 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ARTANE trihexyphenidyl hydrochloride TABLET;ORAL 006773-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.